Source: forbes.com Author: Thomas Stossel This year’s Lasker Foundation annual prize for medical breakthroughs–the American version of the Nobel Prize–recognizes a breakthrough cancer treatment that has revolutionized chemotherapy, a “targeted therapy for chronic myelogenous leukemia.” But more symbolic–and no doubt controversial–was to whom the prize was awarded: two academic scientists and a former drug company [...]
Continue reading...
Thursday, October 15, 2009
0 Comments